Viewing Study NCT02067156


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT02067156
Status: COMPLETED
Last Update Posted: 2024-05-21
First Post: 2014-02-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma
Sponsor: GenSpera, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glioblastoma View